Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations

BACKGROUND: To characterize the effects of mutation subtypes and concomitant pathogenic mutations on progression-free survival (PFS) and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yue, Li, Jingwen, Zhou, Yan, Cao, Shuhui, Ling, Xuxinyi, Zhang, Yao, Nie, Wei, Zhong, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661900/
https://www.ncbi.nlm.nih.gov/pubmed/33209877
http://dx.doi.org/10.21037/atm-20-6172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661900/
https://www.ncbi.nlm.nih.gov/pubmed/33209877
http://dx.doi.org/10.21037/atm-20-6172

Ejemplares similares